Elhadi K, Daiwile A, Cadet J
Neurosci Biobehav Rev. 2024; 155:105440.
PMID: 38707245
PMC: 11068368.
DOI: 10.1016/j.neubiorev.2023.105440.
Sotoyama H, Namba H, Tohmi M, Nawa H
Biomolecules. 2023; 13(2).
PMID: 36830741
PMC: 9953688.
DOI: 10.3390/biom13020372.
Yang G, Cui M, Jiang W, Sheng J, Yang Y, Zhang X
Aging (Albany NY). 2021; 13(12):16859-16872.
PMID: 34182543
PMC: 8266367.
DOI: 10.18632/aging.203200.
Vasudevaraja V, Rodriguez J, Pelorosso C, Zhu K, Buccoliero A, Onozato M
J Neuropathol Exp Neurol. 2020; 80(2):160-168.
PMID: 33274363
PMC: 8502434.
DOI: 10.1093/jnen/nlaa137.
Linnerbauer M, Rothhammer V
Front Immunol. 2020; 11:573256.
PMID: 33117368
PMC: 7561408.
DOI: 10.3389/fimmu.2020.573256.
Role of EGFR in the Nervous System.
Romano R, Bucci C
Cells. 2020; 9(8).
PMID: 32806510
PMC: 7464966.
DOI: 10.3390/cells9081887.
Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease.
Virachit S, Mathews K, Cottam V, Werry E, Galli E, Rappou E
Brain Pathol. 2019; 29(6):813-825.
PMID: 31033033
PMC: 8028639.
DOI: 10.1111/bpa.12730.
Astrocyte-Like Cells Differentiated from Dental Pulp Stem Cells Protect Dopaminergic Neurons Against 6-Hydroxydopamine Toxicity.
Ganapathy K, Datta I, Bhonde R
Mol Neurobiol. 2018; 56(6):4395-4413.
PMID: 30327976
DOI: 10.1007/s12035-018-1367-3.
mGluR1-Dependent Long Term Depression in Rodent Midbrain Dopamine Neurons Is Regulated by Neuregulin 1/ErbB Signaling.
Ledonne A, Mercuri N
Front Mol Neurosci. 2018; 11:346.
PMID: 30327588
PMC: 6174199.
DOI: 10.3389/fnmol.2018.00346.
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.
Lim N, Swanson C, Cherng H, Unger T, Xie S, Weintraub D
Ann Clin Transl Neurol. 2016; 3(5):346-55.
PMID: 27231704
PMC: 4863747.
DOI: 10.1002/acn3.299.
Fingolimod induces neuroprotective factors in human astrocytes.
Hoffmann F, Hofereiter J, Rubsamen H, Melms J, Schwarz S, Faber H
J Neuroinflammation. 2015; 12:184.
PMID: 26419927
PMC: 4589103.
DOI: 10.1186/s12974-015-0393-6.
Presenilin 1 is necessary for neuronal, but not glial, EGFR expression and neuroprotection via γ-secretase-independent transcriptional mechanisms.
Bruban J, Voloudakis G, Huang Q, Kajiwara Y, Rahim M, Yoon Y
FASEB J. 2015; 29(9):3702-12.
PMID: 25985800
PMC: 4550373.
DOI: 10.1096/fj.15-270645.
Dopamine D2 receptor-mediated epidermal growth factor receptor transactivation through a disintegrin and metalloprotease regulates dopaminergic neuron development via extracellular signal-related kinase activation.
Yoon S, Baik J
J Biol Chem. 2013; 288(40):28435-46.
PMID: 23955337
PMC: 3789945.
DOI: 10.1074/jbc.M113.461202.
Essential roles of heparin-binding epidermal growth factor-like growth factor in the brain.
Oyagi A, Hara H
CNS Neurosci Ther. 2012; 18(10):803-10.
PMID: 23006514
PMC: 6493631.
DOI: 10.1111/j.1755-5949.2012.00371.x.
Secreted phospholipase A2-IIA-induced a phenotype of activated microglia in BV-2 cells requires epidermal growth factor receptor transactivation and proHB-EGF shedding.
Martin R, Cordova C, Nieto M
J Neuroinflammation. 2012; 9:154.
PMID: 22747893
PMC: 3488565.
DOI: 10.1186/1742-2094-9-154.
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.
Chen-Plotkin A, Hu W, Siderowf A, Weintraub D, Gross R, Hurtig H
Ann Neurol. 2011; 69(4):655-63.
PMID: 21520231
PMC: 3155276.
DOI: 10.1002/ana.22271.
A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2.
Murata H, Sakaguchi M, Jin Y, Sakaguchi Y, Futami J, Yamada H
J Biol Chem. 2010; 286(9):7182-9.
PMID: 21177249
PMC: 3044975.
DOI: 10.1074/jbc.M110.179390.
Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells.
Zhou Y, Besner G
Neurosignals. 2010; 18(3):141-51.
PMID: 20847549
PMC: 3068752.
DOI: 10.1159/000319823.
Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice.
Oyagi A, Oida Y, Kakefuda K, Shimazawa M, Shioda N, Moriguchi S
PLoS One. 2009; 4(10):e7461.
PMID: 19829704
PMC: 2759290.
DOI: 10.1371/journal.pone.0007461.
A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor.
Mizuno M, Sotoyama H, Narita E, Kawamura H, Namba H, Zheng Y
J Neurosci. 2007; 27(38):10116-27.
PMID: 17881518
PMC: 6672673.
DOI: 10.1523/JNEUROSCI.2368-07.2007.